ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1,4,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
8,1,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
9,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
9,3,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
10,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
10,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
11,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
12,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
12,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
13,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
13,2,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
14,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
15,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
16,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
17,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
18,1,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
18,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
19,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
21,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
21,2,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
22,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
22,2,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
22,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
23,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
23,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
26,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
26,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
26,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
27,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
28,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
29,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
30,1,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
30,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
31,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
32,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
32,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
34,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
34,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
35,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
36,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
37,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
37,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
37,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
38,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
39,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
40,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
41,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
42,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
43,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
43,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
43,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
44,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
45,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
46,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
46,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
46,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
46,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
46,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
46,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
46,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
47,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
48,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
49,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
50,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
52,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
52,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
53,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
54,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
54,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
55,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
56,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
59,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
59,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
59,3,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
59,4,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
59,5,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
59,6,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
59,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
59,8,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
59,9,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
59,10,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
60,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
61,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
62,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
64,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
64,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
65,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
66,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
66,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
66,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
66,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
66,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
66,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
66,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
66,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
66,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
66,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
66,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
66,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
66,13,Vaccination site inflammation,Vaccination site reactions,Administration site reactions,Genrl,N
67,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
67,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
67,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
67,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
67,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
67,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
68,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
68,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
68,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
68,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
69,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
69,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
70,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
70,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
71,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
71,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
72,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
72,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
72,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
72,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
72,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
72,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
72,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
73,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
74,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
74,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
75,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
75,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
76,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
76,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
77,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
77,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
78,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
78,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
80,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
80,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
81,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
82,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
83,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
83,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
83,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
83,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
83,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
83,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
84,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
85,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
85,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
86,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
86,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
87,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
87,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
87,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
87,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
87,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
88,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
88,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
